UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 54

Sortiert nach

Pembrolizumab for the first-line treatment of non-small cell lung cancer

Expert opinion on biological therapy, 2018-10, Vol.18 (10), p.1015-1021

2018

Link zum Volltext

Verfügbarkeit prüfen

A Phase II Study of Trastuzumab Emtansine in HER2-Positive Non–Small Cell Lung Cancer

Journal of thoracic oncology, 2018-02, Vol.13 (2), p.273-279

2018

Link zum Volltext

Verfügbarkeit prüfen

The effect and safety of immune checkpoint inhibitor rechallenge in non-small cell lung cancer

Japanese journal of clinical oncology, 2019-08, Vol.49 (8), p.762-765

2019

Link zum Volltext

Verfügbarkeit prüfen

Immune checkpoint inhibitor efficacy and safety in older non-small cell lung cancer patients

Japanese journal of clinical oncology, 2020-12, Vol.50 (12), p.1447-1453

2020

Link zum Volltext

Verfügbarkeit prüfen

Congestive Heart Failure During Osimertinib Treatment for Epidermal Growth Factor Receptor (EGFR)-mutant Non-small Cell Lung Cancer (NSCLC)

Internal Medicine, 2017/08/15, Vol.56(16), pp.2195-2197

2017

Link zum Volltext

Verfügbarkeit prüfen

MET or NRAS amplification is an acquired resistance mechanism to the third-generation EGFR inhibitor naquotinib

Scientific reports, 2018-01, Vol.8 (1), p.1955-11, Article 1955

2018

Link zum Volltext

Verfügbarkeit prüfen

A suspected case of rocuronium–sugammadex complex-induced anaphylactic shock after cesarean section

Journal of anesthesia, 2017-02, Vol.31 (1), p.148-151

2017

Link zum Volltext

Verfügbarkeit prüfen

Significance of re-biopsy of histological tumor samples in advanced non-small-cell lung cancer in clinical practice

International journal of clinical oncology, 2019-01, Vol.24 (1), p.41-45

2019

Link zum Volltext

Verfügbarkeit prüfen

SHP2 Inhibition Enhances the Effects of Tyrosine Kinase Inhibitors in Preclinical Models of Treatment-naïve ALK-, ROS1- , or EGFR -altered Non-small Cell Lung Cancer

Molecular cancer therapeutics, 2021-09, Vol.20 (9), p.1653-1662

2021

Link zum Volltext

Verfügbarkeit prüfen

Beneficial effect of erlotinib and trastuzumab emtansine combination in lung tumors harboring EGFR mutations

Biochemical and biophysical research communications, 2020-11, Vol.532 (3), p.341-346

2020

Link zum Volltext

Verfügbarkeit prüfen

Influence of age on the efficacy of immune checkpoint inhibitors in advanced cancers: a systematic review and meta-analysis

Acta oncologica, 2020-03, Vol.59 (3), p.249-256

2020

Link zum Volltext

Verfügbarkeit prüfen

Re-administration of osimertinib in osimertinib-acquired resistant non-small-cell lung cancer

Lung cancer (Amsterdam, Netherlands), 2019-06, Vol.132, p.54-58

2019

Link zum Volltext

Verfügbarkeit prüfen

A randomized trial of sodium alginate prevention of esophagitis in LA-NSCLC receiving chemoradiotherapy: OLCSG1401

Supportive care in cancer, 2021-09, Vol.29 (9), p.5237-5244

2021

Link zum Volltext

Verfügbarkeit prüfen

Severe Cytokine Release Syndrome and Immune Effector Cell-associated Neurotoxicity Syndrome in a Man Receiving Immune Checkpoint Inhibitors for Lung Cancer

Internal medicine (Tokyo, 1992), 2024-05, Vol.63 (9), p.1261-1267

2024

Link zum Volltext

Verfügbarkeit prüfen

Pulmonary Aspergilloma and Allergic Bronchopulmonary Aspergillosis Following the 2018 Heavy Rain Event in Western Japan

Internal Medicine, 2022/02/01, Vol.61(3), pp.379-383

2022

Link zum Volltext

Verfügbarkeit prüfen

A Prompt Diagnosis and Treatment of a Case of Nuclear Protein of the Testis Carcinoma Characterized by a Bronchial Lesion and High Serum Alpha-fetoprotein Level Following Genomic Testing

Internal Medicine, 2024, pp.2938-23

2024

Link zum Volltext

Verfügbarkeit prüfen

A Unique Case of Sarcoid-associated Myelopathy Accompanied by Lung Cancer

Internal Medicine, 2023/12/01, Vol.62(23), pp.3531-3535

2023

Link zum Volltext

Verfügbarkeit prüfen

EGFR-TKI acquired resistance in lung cancers harboring EGFR mutations in immunocompetent C57BL/6J mice

Lung cancer (Amsterdam, Netherlands), 2019-10, Vol.136, p.86-93

2019

Link zum Volltext

Verfügbarkeit prüfen

Impact of HER2 expression on EGFR-TKI treatment outcomes in lung tumors harboring EGFR mutations: A HER2-CS study subset analysis

Lung cancer (Amsterdam, Netherlands), 2020-12, Vol.150, p.83-89

2020

Link zum Volltext

Verfügbarkeit prüfen

肺癌診療ガイドライン改訂のポイント―薬物療法の領域を中心に

肺癌, 2023/11/02, Vol.63(Supplement), pp.804-805

2023

Link zum Volltext

Verfügbarkeit prüfen

Comparison of bronchoscopy and computed tomography-guided needle biopsy for re-biopsy in non-small cell lung cancer patients

Respiratory investigation, 2021-03, Vol.59 (2), p.240-246

2021

Link zum Volltext

Verfügbarkeit prüfen

Programmed cell death-ligand 1 expression and efficacy of cisplatin-based chemotherapy in lung cancer: A sub-analysis of data from the two Okayama Lung Cancer Study Group prospective feasibility studies

Respiratory investigation, 2019-09, Vol.57 (5), p.460-465

2019

Link zum Volltext

Verfügbarkeit prüfen

Patients' preferences and perceptions of lung cancer treatment decision making: results from Okayama lung cancer study group trial 1406

Acta oncologica, 2020-03, Vol.59 (3), p.324-328

2020

Link zum Volltext

Verfügbarkeit prüfen

Detection of epidermal growth factor receptor mutations in exhaled breath condensate using droplet digital polymerase chain reaction

Oncology letters, 2020-12, Vol.20 (6), p.1-1

2020

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 54

Suche als RSS-Feed

Aktive Filter

SpracheJapanisch

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(38)
Mit Volltextzugriff
(48)

Publikationsform

Artikel
(54)

Sprache

Englisch
(35)

Erscheinungsjahr

n.n

Thema

Science & Technology
(28)
Life Sciences & Biomedicine
(27)
Humans
(24)
Female
(20)
Oncology
(18)
Lung Cancer
(14)
Aged
(13)
Cancer Research
(13)
Male
(12)
Lung Neoplasms - Drug Therapy
(11)
Middle Aged
(11)
Pulmonary And Respiratory Medicine
(10)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(9)
Non-Small Cell Lung Cancer
(8)
Adult
(7)
General Medicine
(7)
Immune Checkpoint Inhibitor
(7)
Lung Neoplasms - Genetics
(7)
Respiratory System
(7)
Carcinoma, Non-Small-Cell Lung - Genetics
(6)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Pembrolizumab for the first-line treatment of non-small cell lung cancer

A Phase II Study of Trastuzumab Emtansine in HER2-Positive Non–Small Cell Lung Cancer

VEGFR2 blockade augments the effects of tyrosine kinase inhibitors by inhibiting angiogenesis and oncogenic signaling in oncogene‐driven non‐small‐cell lung cancers

The effect and safety of immune checkpoint inhibitor rechallenge in non-small cell lung cancer

Immune checkpoint inhibitor efficacy and safety in older non-small cell lung cancer patients

Congestive Heart Failure During Osimertinib Treatment for Epidermal Growth Factor Receptor (EGFR)-mutant Non-small Cell Lung Cancer (NSCLC)

MET or NRAS amplification is an acquired resistance mechanism to the third-generation EGFR inhibitor naquotinib

A suspected case of rocuronium–sugammadex complex-induced anaphylactic shock after cesarean section

Significance of re-biopsy of histological tumor samples in advanced non-small-cell lung cancer in clinical practice

SHP2 Inhibition Enhances the Effects of Tyrosine Kinase Inhibitors in Preclinical Models of Treatment-naïve ALK-, ROS1- , or EGFR -altered Non-small Cell Lung Cancer

Beneficial effect of erlotinib and trastuzumab emtansine combination in lung tumors harboring EGFR mutations

Influence of age on the efficacy of immune checkpoint inhibitors in advanced cancers: a systematic review and meta-analysis

Re-administration of osimertinib in osimertinib-acquired resistant non-small-cell lung cancer

A randomized trial of sodium alginate prevention of esophagitis in LA-NSCLC receiving chemoradiotherapy: OLCSG1401

Severe Cytokine Release Syndrome and Immune Effector Cell-associated Neurotoxicity Syndrome in a Man Receiving Immune Checkpoint Inhibitors for Lung Cancer

Pulmonary Aspergilloma and Allergic Bronchopulmonary Aspergillosis Following the 2018 Heavy Rain Event in Western Japan

A Prompt Diagnosis and Treatment of a Case of Nuclear Protein of the Testis Carcinoma Characterized by a Bronchial Lesion and High Serum Alpha-fetoprotein Level Following Genomic Testing

A Unique Case of Sarcoid-associated Myelopathy Accompanied by Lung Cancer

EGFR-TKI acquired resistance in lung cancers harboring EGFR mutations in immunocompetent C57BL/6J mice

Impact of HER2 expression on EGFR-TKI treatment outcomes in lung tumors harboring EGFR mutations: A HER2-CS study subset analysis

肺癌診療ガイドライン改訂のポイント―薬物療法の領域を中心に

Comparison of bronchoscopy and computed tomography-guided needle biopsy for re-biopsy in non-small cell lung cancer patients

Programmed cell death-ligand 1 expression and efficacy of cisplatin-based chemotherapy in lung cancer: A sub-analysis of data from the two Okayama Lung Cancer Study Group prospective feasibility studies

Patients' preferences and perceptions of lung cancer treatment decision making: results from Okayama lung cancer study group trial 1406

Detection of epidermal growth factor receptor mutations in exhaled breath condensate using droplet digital polymerase chain reaction

Aktive Filter

Suchergebnisse filtern